PROVECTUS BIOPHARMACEUTICALS, INC. Annual Operating Margin in % from 2022 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Provectus Biopharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from 2022 to 2023.
  • Provectus Biopharmaceuticals, Inc. Operating Margin for the quarter ending September 30, 2024 was -387 %, a 21.9% increase year-over-year.
  • Provectus Biopharmaceuticals, Inc. annual Operating Margin for 2023 was -520 %, a 50.1% decline from 2022.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -520 -174 -50.1% Jan 1, 2023 Dec 31, 2023
2022 -347 Jan 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.